Animal studies have demonstrated that GALP deficiency exacerbates high-fat diet-induced glucose intolerance, and the observed reduction in GALP levels in obese PCOS patients may promote chronic inflammation and lipid metabolism dysregulation, collectively driving GDM development (54). Here, GALP is linked to polycystic ovary syndrome.